BRITTANY CATIZONE: Open Payments
NPI 1255963336 · LA PORTE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,066 in 115 payments from 19 companies in 2025. Trend: 2023 $1,422 · 2024 $1,687 · 2025 $2,066
Food & beverage: $2,066
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 22 | $363 |
| Novo Nordisk Inc | 19 | $278 |
| AstraZeneca Pharmaceuticals LP | 9 | $196 |
| Amgen Inc. | 15 | $174 |
| Lilly USA, LLC | 8 | $173 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 8 | $170 |
| PFIZER INC. | 7 | $123 |
| Sumitomo Pharma America, Inc. | 4 | $90 |
| GlaxoSmithKline, LLC. | 4 | $80 |
| Exact Sciences Corporation | 3 | $67 |
Products named: VRAYLAR, CAPLYTA, AIRSUPRA, OTEZLA, MOUNJARO, UBRELVY, NURTEC ODT, Cologuard Collection Kit.
Industry payments across IN — which companies pay providers there.
